By Matt Harrington, BCBA · Behaviorist Book Club · April 2026 · 12 min read

Mental Health Parity and ABA Coverage: Navigating MHPAEA and California SB 855

Overview & Clinical Significance

Access to adequate insurance coverage for ABA services is one of the most consequential advocacy issues in the field today. Two laws — the federal Mental Health Parity and Addiction Equity Act (MHPAEA) and California's Senate Bill 855 — create a legal framework that ABA providers must understand not only to protect their clients' coverage rights but to advocate effectively within the insurance ecosystem.

For BCBAs practicing in California, SB 855 represents a landmark expansion of coverage mandates. Signed into law in 2020, it requires that state-regulated health insurance plans provide coverage for the treatment of all mental health and substance use disorders as defined by the Diagnostic and Statistical Manual of Mental Disorders — a definition that encompasses ASD and the ABA interventions used to treat it. Understanding its provisions enables practitioners to challenge inappropriate denials and support families navigating insurance disputes.

The federal MHPAEA, enacted in 2008 and strengthened through subsequent regulatory action, prohibits health plans from imposing more restrictive limitations on mental health and substance use disorder benefits than those applied to comparable medical and surgical benefits. For ABA providers, this means that prior authorization requirements, visit limits, and medical necessity criteria applied to ABA services must be measured against the standards applied to analogous medical treatments. Recent enforcement actions have made this parity analysis more tractable for providers and advocates.

Lorri Unumb, who presents this course, brings deep expertise in insurance advocacy for the autism community, having been involved in ABA insurance mandates nationally for years. Her practical legal perspective is especially valuable for BCBAs who regularly encounter insurance barriers but lack the legal framework to push back effectively.

This knowledge directly enables better client outcomes: families who receive adequate insurance coverage can access the intensity of ABA services that produces meaningful skill development, while families whose coverage is improperly limited must reduce service hours, often at critical developmental windows.

Background & Context

The Mental Health Parity and Addiction Equity Act of 2008 built on earlier federal parity legislation (the Mental Health Parity Act of 1996) by requiring that when health plans offer mental health or substance use disorder coverage, the financial requirements and treatment limitations for those benefits must be no more restrictive than those applied to medical and surgical benefits. The law applies to group health plans with more than 50 employees and to individual and small group plans under the Affordable Care Act.

Despite MHPAEA's passage over 15 years ago, enforcement was historically weak. The law's requirements were complex, and many plans continued to impose discriminatory limitations on behavioral health benefits without meaningful consequence. Beginning around 2020, however, the Department of Labor intensified enforcement efforts, requiring health plans to conduct comparative analyses demonstrating parity compliance. This enforcement shift has given behavioral health advocates new tools to challenge discriminatory plan designs.

California SB 855 addressed gaps that MHPAEA left open. Because MHPAEA is a parity law — it requires equal treatment but does not mandate coverage in the first place — states with weak existing mental health coverage mandates could still provide minimal behavioral health benefits as long as they were equal to equally minimal medical benefits. SB 855 changed this in California by mandating that state-regulated plans cover all DSM-defined conditions using evidence-based treatments, removing the legal basis for categorical exclusions of ABA services.

For ABA providers, the practical history of insurance denials is important context. Common denial tactics have included characterizing ABA as educational rather than medical, applying arbitrary visit caps not applied to comparable physical health treatments, and requiring excessive prior authorization hurdles. Both MHPAEA and SB 855 provide legal bases for challenging each of these practices.

The distinction between self-funded ERISA plans (governed by federal law, not state insurance mandates) and fully insured state-regulated plans is critical. SB 855 does not apply to self-funded employer plans, which are exempt from state insurance regulation. This creates coverage disparities depending on how a family's employer structures its benefits.

Clinical Implications

BCBAs frequently serve as the primary interface between families and insurance systems when coverage disputes arise. While BCBAs are not attorneys and cannot provide legal advice, they can play a critical role in documenting medical necessity, providing clinical justification for treatment intensity, and connecting families with advocacy resources.

Medical necessity documentation is the clinical foundation of insurance advocacy. When ABA services are denied as not medically necessary, the denial is typically based on clinical criteria that the insurer has established — criteria that must, under MHPAEA, be comparable to those applied to analogous medical benefits. BCBAs who understand the parity framework can write more effective medical necessity letters by explicitly addressing the treatment criteria at issue and demanding disclosure of the comparative criteria the insurer applies to medical benefits.

Prior authorization practices are a common site of parity violations. Some plans require extensive documentation for initial ABA authorization but apply no comparable requirements for physical therapy or occupational therapy. BCBAs who track the authorization requirements they face — including turnaround times, documentation requirements, and denial rates — generate data that supports parity complaints.

Step therapy requirements, which force patients to try lower-intensity interventions before authorizing higher levels of care, have been applied to ABA in ways that may violate MHPAEA if comparable requirements are not applied to medical benefits. When insurers require that clients "try" less intensive services before authorizing comprehensive ABA, BCBAs can evaluate whether this requirement has clinical basis and whether it is applied consistently across benefit types.

Clinical documentation should be calibrated to insurance requirements without compromising accuracy. This means understanding what insurers are looking for in prior authorization requests: evidence of diagnosis, functional impairment, treatment goals tied to remediating that impairment, and a rationale for the specific intervention modality and intensity requested.

Ethical Considerations

The Ethics Code is directly implicated when insurance barriers prevent clients from receiving clinically indicated ABA services. Code 2.01 (Providing Effective Treatment) requires behavior analysts to recommend and implement only treatments that are supported by evidence and tailored to the client's specific needs. When insurance limitations force service reductions below what clinical assessment indicates is necessary, BCBAs face an ethical tension between what the evidence supports and what the funding environment permits.

Code 3.01 (Behavior-Analytic Assessment) requires that assessments are conducted prior to developing treatment programs and that the results are used to guide intervention. When insurance companies impose arbitrary limitations on assessment types or frequency, they can undermine the assessment-driven treatment planning that is foundational to ethical ABA practice. BCBAs should document when insurance constraints are compromising their ability to conduct appropriate assessments and communicate these limitations clearly to caregivers.

Code 1.11 (Advocacy) reflects the field's collective responsibility to advocate for systems that support ethical practice. Understanding MHPAEA and SB 855 is a prerequisite for meaningful advocacy. BCBAs who encounter discriminatory insurance practices have an ethical basis — and arguably an ethical obligation — to report these practices to state insurance regulators and to support families in exercising their appeal rights.

The obligation of informed consent (Code 4.02) extends to helping clients and families understand their insurance rights. When a family receives a denial letter that may be legally challengeable, the BCBA who is unaware of parity laws cannot fully inform the family of their options. Developing working knowledge of MHPAEA and SB 855 enables practitioners to fulfill their informed consent obligations more completely.

Conflicts of interest considerations (Code 6.01) arise when financial pressures from insufficient reimbursement influence clinical decision-making. BCBAs should be aware of how insurance coverage environments affect their clinical recommendations and ensure that decisions about treatment intensity, setting, and duration are driven by client need rather than reimbursement availability.

Assessment & Decision-Making

When an ABA service is denied or limited by insurance, a systematic assessment of the denial's legal basis is the starting point for effective response. The first question is whether the plan is subject to MHPAEA, SB 855, or both. As noted, self-funded employer plans are not subject to state mandates, but they are subject to MHPAEA. Fully insured California plans are subject to both. The applicability of each law determines the available legal arguments.

For MHPAEA-based challenges, the analytical framework is comparative: what are the nonquantitative treatment limitations (NQTLs) applied to the ABA benefit, and are equivalent or more restrictive NQTLs applied to comparable medical or surgical benefits? NQTLs include prior authorization requirements, step therapy protocols, network adequacy standards, and medical necessity criteria. Obtaining the plan's medical necessity criteria and comparative analysis documentation — which the plan is required to provide upon request — is an essential first step.

For SB 855-based challenges, the key question is whether the plan is denying coverage for a DSM-defined condition or an evidence-based treatment for that condition, and whether the plan is a California state-regulated plan. If both conditions are met, the denial may directly violate the law's coverage mandate.

The appeals process is the primary vehicle for challenging insurance denials. First-level internal appeals to the insurance company are required before external review. External Independent Medical Review (IMR) through the California Department of Managed Health Care is available for clinical denials by California HMO plans and has historically produced favorable outcomes for ABA services. External appeals through the California Department of Insurance are available for PPO and other indemnity plans.

BCBAs contribute most effectively to the appeals process by providing clear, thorough clinical documentation that addresses the specific basis for denial. This requires reading denial letters carefully, identifying the stated clinical rationale, and responding to that rationale with evidence-based counterarguments.

What This Means for Your Practice

Developing practical insurance advocacy competence is increasingly a core professional skill for BCBAs. This does not mean becoming an insurance attorney, but it does mean building enough foundational knowledge to identify when families are being treated unfairly and to know what resources can help.

Create a denial tracking system in your practice. Log every authorization denial, including the stated reason, the insurer, the plan type, and the outcome of any appeals. Over time, this data reveals patterns — insurers with systematically problematic denial rates, specific CPT codes that face disproportionate denials, or populations (e.g., adult clients) who face more significant coverage barriers. This data supports both individual client advocacy and collective advocacy efforts.

Develop relationships with insurance advocacy organizations and legal aid resources in your area. In California, organizations like Autism Speaks' California chapter, the Disability Rights Legal Center, and the DHMC have historically supported families challenging ABA coverage denials. Knowing who to refer families to when the situation exceeds your clinical advocacy role is part of comprehensive care coordination.

Review your medical necessity documentation templates with MHPAEA in mind. Strong medical necessity letters for ABA services address: the specific DSM diagnosis, the functional impairments resulting from that diagnosis, the evidence base for ABA as a treatment for those impairments, the proposed treatment goals and their relationship to functional outcomes, and the clinical rationale for the requested intensity and setting. Templates that address all of these elements are more likely to withstand utilization review scrutiny.

Stay current on enforcement developments. Federal and state agencies have increased enforcement activity related to mental health parity, and case law continues to evolve. Annual review of updates from DHMC, CaDI, and BACB regarding insurance practice developments helps practitioners maintain an effective advocacy posture.